Publications by authors named "Thorben Gross"

Claim this Profile
I
Immune checkpoint inhibition alters patterns of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy.
Julian Taugner, Silja Stamer, Kerstin Hofstetter, Chukwuka Eze, Lukas Käsmann

J Cancer Res Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.
Axel Gschwind, Nadja Ballin, Alexander Ott, Andrea Forschner, Amelie Knapp

Biology (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-activity [F]-somatostatin receptor (SSTR) imaging using [F]SiTATE on a long axial field-of-view PET/CT scanner.
Nils F Trautwein, Eduardo Calderón, Pia M Linder, Gerald Reischl, Philippe Driessen

EJNMMI Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations" [Eur J Cancer 207 (2024) 114158].
Anna Kron, Matthias Scheffler, Marcel Wiesweg, Horst-Dieter Hummel, Jonas Kulhavy

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations.
Anna Kron, Matthias Scheffler, Marcel Wiesweg, Horst-Dieter Hummel, Jonas Kulhavy

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Linus D Kloker, Mirjana Sidiras, Tim Flaadt, Ines B Brecht, Christoph K W Deinzer

Lung Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Fiamma Berner, David Bomze, Christa Lichtensteiger, Vincent Walter, Rebekka Niederer, Thorben Gross

Sci Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Fiamma Berner, Rebekka Niederer, Jolien J Luimstra, Oltin Tiberiu Pop, Ann-Kristin Jochum, Thorben Gross

Oncoimmunology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Sclerosing epithelioid fibrosarcoma: A rare pathologic entity].
Karolin Baumgartner, Hans Bösmüller, Thorben Gross, Christian Mueller-Horvat, Jan Fritz

Rofo· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.
Markus W Löffler, Bianca Nussbaum, Günter Jäger, Philipp S Jurmeister, Jan Budczies, Thorben H Gross

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancer.
Maik Häntschel, Johannes Niebling, Almut Häring, Max-Felix Häring, Thorben Groß

Thorac Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis